Argenica Therapeutics Ltd
ASX:AGN

Watchlist Manager
Argenica Therapeutics Ltd Logo
Argenica Therapeutics Ltd
ASX:AGN
Watchlist
Price: 0.255 AUD -1.92% Market Closed
Market Cap: 32.8m AUD

Operating Margin
Argenica Therapeutics Ltd

-1 990.9%
Current
-31 673%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 990.9%
=
Operating Profit
-10.2m
/
Revenue
512.8k

Operating Margin Across Competitors

No Stocks Found

Argenica Therapeutics Ltd
Glance View

Market Cap
32.8m AUD
Industry
Pharmaceuticals

Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. Argenica’s lead candidate, ARG-007, aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury. Argenica has accumulated a comprehensive body of published pre-clinical studies demonstrating efficacy of ARG-007 in multiple models of stroke and other central nervous system injury models, including stroke, traumatic brain injury and perinatal hypoxia ischaemia.

AGN Intrinsic Value
0.043 AUD
Overvaluation 83%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 990.9%
=
Operating Profit
-10.2m
/
Revenue
512.8k
What is the Operating Margin of Argenica Therapeutics Ltd?

Based on Argenica Therapeutics Ltd's most recent financial statements, the company has Operating Margin of -1 990.9%.

Back to Top